AI Tools
Recursion OS
Recursion OS: Preise, Fähigkeiten, Updates und Alternativen, von den Seiten des Anbieters gelesen.

Auf Englisch
Key facts
- Price
- Not stated on the maker’s pages
- Free plan
- Not stated on the maker’s pages
- Platforms
- Not stated on the maker’s pages
- API
- Not stated on the maker’s pages
- Open source
- Not presented as open source
- Latest version
- Recursion OS 2.0
- Last update
- 3 Mar 2026 Read on recursion.com
Recursion OS is Recursion’s proprietary platform for drug discovery and development. It combines automated wet-lab experiments, computational analysis, machine learning models, chemistry design, and clinical development workflows in a feedback loop.
Recursion and its pharmaceutical partners use it to identify biological targets, design molecules, validate candidates, and support clinical trial planning. The site does not show public self-serve plans or pricing, and the platform is not presented as a general-purpose consumer AI tool.
- Category
- Research & Education
- Read from the maker’s pages
- 2026-09-19
Company
Features
- Maps disease biology with high-dimensional cellular experiments
- Generates digital representations of biological and chemical experiments
- Uses machine learning and purpose-built large language models
- Supports target identification and biological insight generation
- Designs potential medicines with generative de novo chemistry
- Connects automated wet labs with computational analysis
- Supports clinical development and trial enrollment workflows
- Includes Recursion OS 2.0 workflows for biology, design, and clinical development
Use cases
- Identify disease-relevant biological targets
- Design and prioritize potential drug compounds
- Run integrated design-make-test-learn cycles
- Validate computational predictions in automated laboratories
- Select patients and support clinical trial execution
Latest updates
- Unlocking the First Neuroscience Target for the Recursion and Genentech Collaboration
Unlocking a neuroscience target for the Recursion and Genentech collaboration.
- New Data’s Not Enough. How Recursion Is Integrating Data Layers to Advance End-to-End Drug Discovery
Integrating data layers to advance end-to-end drug discovery.
- Since Its Inception, Recursion has Been Building the Foundation for the First Virtual Cell
Building the foundation for a virtual cell.
- How a First-of-its-Kind “Microglia Map” from Recursion and Roche and Genentech Could Unlock New Treatments for Neurodegenerative Diseases
A microglia map from Recursion and Roche and Genentech could unlock treatments.
- The Quest for Better Protein-Ligand Interaction Modeling – Improving ML Methods Offer Promise for AI Drug Discovery
Improving ML methods for protein-ligand interaction modeling.
Questions about Recursion OS
Is Recursion OS open source?
The maker’s pages do not present Recursion OS as open source. Read on the maker’s pages on 19 Sept 2026.
Is Recursion OS still available?
Yes, as of 19 Sept 2026: its maker’s pages were read that day and carried no notice that Recursion OS has ended.
What changed recently in Recursion OS?
The latest entry in its maker’s changelog: 3 Mar 2026, “Unlocking the First Neuroscience Target for the Recursion and Genentech Collaboration”. Before it: 4 Dec 2025, “New Data’s Not Enough. How Recursion Is Integrating Data Layers to Advance End-to-End Drug Discovery”. Changelog checked on 17 Nov 2026.
Sources
- https://www.recursion.com/platform — Product page describing Recursion OS, its workflows, data, models, automated labs, and clinical development capabilities.
- https://www.recursion.com/faq — FAQ defining Recursion OS as a full-stack AI-native platform integrating wet-lab experimentation with in-silico analysis.
- https://recursion.com/news/unlocking-the-first-neuroscience-target-for-the-recursion-and-genentech-collaboration — August 5, 2026 announcement about the first neuroscience target advanced through the Recursion-Genentech collaboration.
- https://www.recursion.com/blogs — Official blog index showing the latest dated company posts available during this search.
Not confirmed
- Prices
- No official Recursion OS pricing page was returned or read.
- Official pricing page was not found, so tiers and prices are omitted.
- Free plan
- No official pricing page was found to confirm a free tier.
- API
- The reviewed product pages did not state whether Recursion OS has a public API.
- Platforms
- The reviewed pages did not specify end-user platform support.